Tighter Requirements to Ensure Safer Opioid Prescribing

The FDA has taken action to reduce inappropriate prescribing of transmucosal immediate-release fentanyls (TIRFs) by strengthening the Risk Evaluation and Mitigation Strategies (REMS) program that imposes restrictions on the drugs ’ distribution.

Source: JAMA - February 2, 2021 Category: General Medicine Source Type: research